WuXi AppTec Expands CRDMO Services into Saudi Arabia with NEOM Partnership

WuXi AppTec Expands Its Horizons in Saudi Arabia

In a strategic move to diversify its global reach, WuXi AppTec, the leading global pharmaceutical Contract Research, Development, and Manufacturing Organization (CRDMO), has taken significant steps to establish a foothold in Saudi Arabia. On October 28, 2025, the company announced the signing of two pivotal memoranda of understanding (MoUs) with NEOM and the Kingdom's Ministry of Health (MOH).

NEOM, a transformative project set to redefine the future of urban living in northwest Saudi Arabia, offers an innovative platform for WuXi AppTec's CRDMO operations. The collaboration will focus on localizing pharmaceutical research, development, and production within the region. This partnership aims to construct state-of-the-art CRDMO facilities, particularly in Oxagon, a city designed for advanced and sustainable manufacturing under NEOM's umbrella.

The key objective of this alliance is to harness WuXi AppTec's extensive expertise and global network to stimulate innovation and enhance the growth of the biotechnology sector in Saudi Arabia. The framework established by the MoUs aligns with the country’s ambitious vision for biotechnology, positioning it as a thriving hub in the Middle East.

WuXi AppTec brings decades of experience as a trusted collaborator in the biopharmaceutical landscape. Their advanced CRDMO services will assist in spearheading initiatives aimed at delivering new therapeutic options and healthcare products to patients. This partnership with NEOM promises to significantly bolster Saudi Arabia’s aspirations of becoming a leader in biopharma innovation.

In detail, the MoU with the Ministry of Health is geared towards localizing the pharmaceutical value chain, fostering the development of a skilled workforce, and attracting direct foreign investment into the Saudi healthcare sector. This comprehensive approach is expected to create a robust ecosystem that not only supports the domestic market but also extends its benefits to the broader MENA region.

WuXi AppTec’s mission to facilitate breakthrough discoveries in pharmaceuticals will thrive through this collaboration. The company plays a vital role in supporting over 6,000 partners in more than 30 countries, thanks to its end-to-end services across research and manufacturing. This move into Saudi Arabia is a testament to WuXi AppTec's commitment to advancing healthcare innovation, driven by their vision that every drug can be developed and every disease treated.

Meanwhile, NEOM is positioning itself as a pioneering project exploring the boundaries of urban development and sustainable living. The venture aims to be more than just a city; it seeks to create an incubator for innovative businesses and a model for exceptional livability. NEOM is designed to include interconnected cities, research centers, and a vibrant business environment supporting various emerging sectors.

The partnership between WuXi AppTec and NEOM reflects a shared vision of progressive innovation and growth, aligning both organizations in their commitment to redefining the future. It accentuates the importance of collaboration in accelerating the growth of the biotechnology sector, while also addressing the pressing needs for healthcare advancements.

As this partnership unfolds, it opens doors not only for WuXi AppTec but also for Saudi Arabia, illustrating a mutual commitment to significantly elevate the healthcare landscape within the region. Through its strategic positioning in NEOM, WuXi AppTec is poised to play a critical role in impacting patients globally, thereby maintaining their trajectory as a leader in the biopharmaceutical industry.

For more information about WuXi AppTec and their revolutionary initiatives, visit www.wuxiapptec.com.

For details about NEOM and its innovative projects, visit www.neom.com.